AIMS/HYPOTHESIS: Uncoupling protein (UCP) 3 is an inner mitochondrial membrane transporter mainly produced in skeletal muscle in humans. UCP3 plays a role in fatty acid metabolism and energy homeostasis and modulates insulin sensitivity. In humans, UCP3 content is higher in fast-twitch glycolytic muscle than in slow-twitch oxidative muscle and is dysregulated in type 2 diabetes. Here, we studied the molecular mechanisms determining human UCP3 levels in skeletal muscle and their regulation by fasting in transgenic mice. METHODS: We produced a series of transgenic lines with constructs bearing different putative regulatory regions of the human UCP3 gene, including promoter and intron sequences. UCP3 mRNA and reporter gene expression and activity were measured in different skeletal muscles and tissues. RESULTS: The profile of expression and the response to fasting and thyroid hormone of human UCP3 mRNA in transgenic mice with 16 kb of the human UCP3 gene were similar to that of the endogenous human gene. Various parts of the UCP3 promoter did not confer expression in transgenic lines. Inclusion of intron 1 resulted in an expression profile in skeletal muscle that was identical to that of human UCP3 mRNA. Further dissection of intron 1 revealed that distinct regions were involved in skeletal muscle expression, distribution among fibre types and response to fasting. CONCLUSIONS/ INTERPRETATION: The control of human UCP3 transcription in skeletal muscle is not solely conferred by the promoter, but depends on several cis-acting elements in intron 1, suggesting a complex interplay between the promoter and intronic sequences.
AIMS/HYPOTHESIS: Uncoupling protein (UCP) 3 is an inner mitochondrial membrane transporter mainly produced in skeletal muscle in humans. UCP3 plays a role in fatty acid metabolism and energy homeostasis and modulates insulin sensitivity. In humans, UCP3 content is higher in fast-twitch glycolytic muscle than in slow-twitch oxidative muscle and is dysregulated in type 2 diabetes. Here, we studied the molecular mechanisms determining humanUCP3 levels in skeletal muscle and their regulation by fasting in transgenic mice. METHODS: We produced a series of transgenic lines with constructs bearing different putative regulatory regions of the humanUCP3 gene, including promoter and intron sequences. UCP3 mRNA and reporter gene expression and activity were measured in different skeletal muscles and tissues. RESULTS: The profile of expression and the response to fasting and thyroid hormone of humanUCP3 mRNA in transgenic mice with 16 kb of the humanUCP3 gene were similar to that of the endogenous human gene. Various parts of the UCP3 promoter did not confer expression in transgenic lines. Inclusion of intron 1 resulted in an expression profile in skeletal muscle that was identical to that of humanUCP3 mRNA. Further dissection of intron 1 revealed that distinct regions were involved in skeletal muscle expression, distribution among fibre types and response to fasting. CONCLUSIONS/ INTERPRETATION: The control of humanUCP3 transcription in skeletal muscle is not solely conferred by the promoter, but depends on several cis-acting elements in intron 1, suggesting a complex interplay between the promoter and intronic sequences.
Authors: M K Hesselink; H A Keizer; L B Borghouts; G Schaart; C F Kornips; L J Slieker; K W Sloop; W H Saris; P Schrauwen Journal: FASEB J Date: 2001-04 Impact factor: 5.191
Authors: C García-Martinez; B Sibille; G Solanes; C Darimont; K Macé; F Villarroya; A M Gómez-Foix Journal: FASEB J Date: 2001-07-24 Impact factor: 5.191
Authors: P Barbe; D Larrouy; C Boulanger; E Chevillotte; N Viguerie; C Thalamas; M Oliva Trastoy; M Roques; H Vidal; D Langin Journal: FASEB J Date: 2000-11-09 Impact factor: 5.191
Authors: P G Cassell; P J Saker; S J Huxtable; E Kousta; A E Jackson; A T Hattersley; T M Frayling; M Walker; P G Kopelman; A Ramachandran; C Snehelatha; G A Hitman; M I McCarthy Journal: Diabetologia Date: 2000-12 Impact factor: 10.122
Authors: Philip Marshall; Nathalie Chartrand; Yves De Repentigny; Rashmi Kothary; Louise Pelletier; Rudi Mueller; Ronald G Worton Journal: Dev Dyn Date: 2002-05 Impact factor: 3.780
Authors: S Larkin; E Mull; W Miao; R Pittner; K Albrandt; C Moore; A Young; M Denaro; K Beaumont Journal: Biochem Biophys Res Commun Date: 1997-11-07 Impact factor: 3.575
Authors: Nolwen Guigal; Marianne Rodriguez; Raquel N Cooper; Sandra Dromaint; James P Di Santo; Vincent Mouly; Jean A Boutin; Jean-Pierre Galizzi Journal: J Biol Chem Date: 2002-09-25 Impact factor: 5.157
Authors: Giuseppina Rose; Paolina Crocco; Francesco De Rango; Alberto Montesanto; Giuseppe Passarino Journal: PLoS One Date: 2011-12-27 Impact factor: 3.240
Authors: Christoph Hoffmann; Anika Zimmermann; Anke Hinney; Anna-Lena Volckmar; Harry W Jarrett; Tobias Fromme; Martin Klingenspor Journal: PLoS One Date: 2013-12-31 Impact factor: 3.240